An announcement from Nuwellis ( ($NUWE) ) is now available. On February 24, 2025, Nuwellis, Inc. announced the retirement of Nestor Jaramillo, Jr.

John Erb, Current Chair of the Board, Appointed Interim President and CEOMINNEAPOLIS, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on ...

Nuwellis (NUWE) announced that Nestor Jaramillo retired as president and CEO and as a director of the company, effective February 18. John Erb, ...

Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that Nestor ...

公司董事会主席John Erb已接任临时总裁兼CEO职务。Erb在这一职位上拥有丰富经验，他曾于2015年11月至2021年1月期间担任Nuwellis的总裁兼CEO。他与公司的渊源可追溯至2012年9月成为董事，并于同年10月担任董事长。根据InvestingPro分析，尽管公司当前比率保持在2.03的稳健水平，但现金消耗速度较快，此时的领导层交接显得尤为关键。

Nuwellis (NUWE) highlighted “promising” findings from an updated analysis of the AVOID-HF study, recently published in the Journal of the ...

Nuwellis, Inc. has announced updated findings from the AVOID-HF study, indicating that the Aquadex® SmartFlow ultrafiltration therapy significantly reduces heart failure events by 60% compared to ...

WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% reductio ...

Orthofix (OFIX) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.10 per share a year ago. These figures are ...

WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% ...